<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02653287</url>
  </required_header>
  <id_info>
    <org_study_id>LIFT Study</org_study_id>
    <nct_id>NCT02653287</nct_id>
  </id_info>
  <brief_title>Lupus Intervention for Fatigue Trial</brief_title>
  <acronym>LIFT</acronym>
  <official_title>Lupus Intervention for Fatigue Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will&#xD;
      be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons&#xD;
      with systemic lupus erythematosus (SLE). The intervention group will receive individual&#xD;
      coaching sessions focusing on physical activity and nutrition while the control group will&#xD;
      receive individual calls in relation to SLE self-management educational sessions.This study&#xD;
      is designed to evaluate the LIFT intervention to decrease fatigue (primary outcome), improve&#xD;
      physical activity (secondary outcome) and dietary behavior (exploratory outcome) in persons&#xD;
      with SLE.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will&#xD;
      be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons&#xD;
      with systemic lupus erythematosus (SLE). The intervention group will receive individual&#xD;
      coaching based in motivational interviewing sessions focusing on physical activity and&#xD;
      nutrition while the control group will receive individual calls focusing on SLE&#xD;
      self-management. This study is designed to evaluate the LIFT intervention to decreased&#xD;
      fatigue (primary outcome), improve physical activity (secondary outcome) and dietary behavior&#xD;
      (exploratory outcome) in persons with SLE.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Fatigue Severity Scale over time</measure>
    <time_frame>Baseline, 3, 6, 12 months</time_frame>
    <description>Online questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Physical Activity Scale over time</measure>
    <time_frame>Baseline, 3, 6, 12 months</time_frame>
    <description>Accelerometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in International Physical Activity Questionnaire (IPAQ) over time</measure>
    <time_frame>Baseline, 3, 6, 12 months</time_frame>
    <description>Phone Interview Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Godin Leisure Time Exercise Questionnaire</measure>
    <time_frame>Baseline, 6, 12 months</time_frame>
    <description>Phone Interview Questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Nutrition Data Systems for Research (NDSR) over time</measure>
    <time_frame>Baseline, 6, 12 months</time_frame>
    <description>Dietary Recall Interview</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Fatigue</condition>
  <condition>Physical Activity</condition>
  <condition>Lupus Erythematosus, Systemic</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental intervention is a unique combination of four individual counseling sessions based in motivational interviewing focusing on physical activity, dietary behavior and behavioral strategies. The individual sessions will provide a tailored personalized intervention including problem-solving and goal setting for increasing physical activity, and following a healthy diet. Healthy Lifestyle Coaches (RN or MPH) will be responsible for conducting the individual for a caseload of participants. There are no drugs involved in the intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group intervention will receive four individual phone calls checking in with participants regarding questions about the study or from the educational sessions focusing on SLE disease management, each lasting approximately 10-15 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Experimental</intervention_name>
    <description>The experimental intervention includes 4 individual coaching sessions (initial 1 hour in-person and remaining 10-15 minutes per telephone) designed to identify barriers and supports for physical activity and nutrition using motivational interviewing. They occur shortly after randomization, 1.5, 3, and 6 months. Daily participants monitor their physical activity via the Fitbit Flex and their dietary behavior on a paper diary.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>The control group will receive four individual phone calls focusing on education for SLE disease management, as well as answering any questions the participants have about the study. Topics include: what is lupus, laboratory tests, medications, taking charge of your health care and managing stress (2 sessions). Each call will last about 10-15 minutes, and occur shortly after randomization, then at 1.5, 3, and 6 months.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  include meeting at least 4 of 11 American College of Rheumatology (ACR) classification&#xD;
             criteria for definite SLE, or 3 out of 11 ACR classification criteria with also&#xD;
             meeting at least one SLICC criteria&#xD;
&#xD;
          -  be at least 18 years of age&#xD;
&#xD;
          -  have a BMI between 18-40 kg/m2&#xD;
&#xD;
          -  be able to ambulate at least household distances (50ft)&#xD;
&#xD;
          -  be able to provide informed consent.&#xD;
&#xD;
          -  be able to speak and read English&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  include pregnancy at baseline&#xD;
&#xD;
          -  not meeting inclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosalind Ramsey-Goldman, MD, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique Kinnett-Hopkins, PhD</last_name>
    <phone>312-503-0869</phone>
    <email>dominique.kinnett-hopkins@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linda Ehrlich-Jones, PhD, RN</last_name>
    <phone>312-238-0743</phone>
    <email>ljones1@sralab.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Holly Milaeger</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holly Milaeger, MPH</last_name>
      <phone>312-503-1919</phone>
      <email>holly.milaeger@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Kinnett-Hopkins, PhD</last_name>
      <phone>312-503-0869</phone>
      <email>dominique.kinnett-hopkins@northwestern.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ramsey-Goldman R, Rothrock N. Fatigue in systemic lupus erythematosus and rheumatoid arthritis. PM R. 2010 May;2(5):384-92. doi: 10.1016/j.pmrj.2010.03.026. Review.</citation>
    <PMID>20656619</PMID>
  </reference>
  <reference>
    <citation>del Pino-Sedeño T, Trujillo-Martín MM, Ruiz-Irastorza G, Cuellar-Pompa L, de Pascual-Medina AM, Serrano-Aguilar P; Spanish Systemic Lupus Erythematosus CPG Development Group. Effectiveness of Nonpharmacologic Interventions for Decreasing Fatigue in Adults With Systemic Lupus Erythematosus: A Systematic Review. Arthritis Care Res (Hoboken). 2016 Jan;68(1):141-8. doi: 10.1002/acr.22675. Review.</citation>
    <PMID>26238554</PMID>
  </reference>
  <reference>
    <citation>Ahn GE, Chmiel JS, Dunlop DD, Helenowski IB, Semanik PA, Song J, Ainsworth B, Chang RW, Ramsey-Goldman R. Self-reported and objectively measured physical activity in adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 May;67(5):701-7. doi: 10.1002/acr.22480.</citation>
    <PMID>25251755</PMID>
  </reference>
  <reference>
    <citation>Mancuso CA, Perna M, Sargent AB, Salmon JE. Perceptions and measurements of physical activity in patients with systemic lupus erythematosus. Lupus. 2011 Mar;20(3):231-42. doi: 10.1177/0961203310383737. Epub 2010 Dec 23.</citation>
    <PMID>21183562</PMID>
  </reference>
  <reference>
    <citation>Ramsey-Goldman R, Schilling EM, Dunlop D, Langman C, Greenland P, Thomas RJ, Chang RW. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res. 2000 Oct;13(5):262-9.</citation>
    <PMID>14635294</PMID>
  </reference>
  <reference>
    <citation>Davies RJ, Lomer MC, Yeo SI, Avloniti K, Sangle SR, D'Cruz DP. Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids. Lupus. 2012 May;21(6):649-55. doi: 10.1177/0961203312436854. Epub 2012 Feb 6.</citation>
    <PMID>22311939</PMID>
  </reference>
  <reference>
    <citation>Lin JS, O'Connor E, Whitlock EP, Beil TL. Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2010 Dec 7;153(11):736-50. doi: 10.7326/0003-4819-153-11-201012070-00007. Review.</citation>
    <PMID>21135297</PMID>
  </reference>
  <reference>
    <citation>Delahanty LM. Research charting a course for evidence-based clinical dietetic practice in diabetes. J Hum Nutr Diet. 2010 Aug;23(4):360-70. doi: 10.1111/j.1365-277X.2010.01065.x. Epub 2010 Apr 27. Review.</citation>
    <PMID>20456590</PMID>
  </reference>
  <reference>
    <citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121-3.</citation>
    <PMID>2803071</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 7, 2016</study_first_submitted>
  <study_first_submitted_qc>January 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2016</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Rosalind Ramsey-Goldman</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fatigue, Physical Activity, Lupus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>It is the intent of all investigators in this project to share any and all resources generated as a result of an award for this project. The final data from this project will be de-identified in accordance with HIPAA guidelines.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

